A Picture is Worth 1000 Words: Skin Manifestations of Systemic Disease
This presentation teaches the nurse practitioner in primary care that the skin can be a wealth of information as to the patient’s diagnosis when the pertinent clues are identified. Reactions of the skin to disease and medications and even internal malignancies can provide clues to diagnosis when you know what to look for. This will be an enlightening presentation!
Credits: 1.00 contact hours; 0.25 are pharmacology
Release Date: March 1, 2021
As a result of this activity, the learner will be able to:
- Compare diseases of the skin with reactions of the skin to diseases
- Review some cutaneous manifestations of internal malignancies, and cardiovascular, rheumatic, and pulmonary disease
- Evaluate some cutaneous reactions to medications
Amelie Hollier, DNP, FNP-BC, FAANP
Advanced Practice Education Associates (APEA)
Dr. Amelie Hollier is a nurse practitioner in family practice in Lafayette, La. She has practiced as an APRN for the last 26 years.
She is President, CEO of Advanced Practice Education Associates (APEA), a nurse practitioner education company. She teaches nurse practitioner review courses across the United States for her company and routinely presents to nurse practitioner groups on pharmacology topics and clinical updates.
In the last 24 years, Amelie has authored, co-authored and edited 25 books for nurse practitioners and nurse practitioner students. Her Clinical Guidelines in Primary Care has been a national best seller. She is Editor in Chief of CareOnPoint, an evidence-based online reference tool for primary care providers. She completed her doctorate of nursing practice at the University of Tennessee in 2007 where her area of study was pharmacotherapeutics. Amelie was inducted as a Fellow in the American Academy of Nurse Practitioners in June 2007.
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
Contributing faculty, Amelie Hollier, DNP, FNP-BC, FAANP, have disclosed no relevant financial relationships.
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There is no commercial support for this activity.
|Access Date||Quiz Result||Score||Actions|